In the ever-evolving landscape of global trade, China's pharmaceutical sector is poised for significant transformations, particularly with recent policy shifts in key regions. As we delve into the implications of Hainan's "sealed operation" – a move that kicked off on December 18, 2025, turning the island into a full-fledged free trade port – it's fascinating to observe how such...

By:DengYue International Business Division Against the backdrop of a profound restructuring of the global innovative drug value chain, China’s pharmaceutical industry is moving toward the center of the international stage at an unprecedented pace. In 2025, the total value of China’s outbound innovative drug licensing (license-out) transactions officially surpassed USD 100 billion,...